CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
By M. Relling, T. Klein. Clinical pharmacology and therapy, 2011
1,075 citations recorded by the source corpus.
The slow rate at which pharmacogenetic tests are being adopted in clinical practice is partly due to the lack of specific guidelines on how to adjust medications on the basis of the genetic test results. One of the goals of the Clinical Pharmacogenetics Implementation Consortium (CPIC) of the National Institutes of Health's Pharmacogenomics Research Network (http://www.pgrn.org) and the Pharmacogenomics Knowledge Base (PharmGKB, http://www.pharmgkb.org) is to provide peer‐reviewed, updated, evidence‐based, freely accessible guidelines for gene/drug pairs. These guidelines will facilitate the translation of pharmacogenomic knowledge from bench to bedside.
Subfields: Genetics, Pediatrics, Perinatology and Child Health, Pharmacology
View Paper: https://www.semanticscholar.org/paper/bc873622d157f1c60fe698be52d4a37a09e79acb
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
In Pediatrics, Perinatology and Child Health
In Pharmacology
Citations in the corpus
- PharmGKB: The Pharmacogenomics Knowledge Base (2013, methodology): “The clinical pharmacogenomics tab displays any dosing guidelines involving the gene published by CPIC (the Clinical Pharmacogenomics Implementation Consortium) [7] and the Royal Dutch Pharmacogenetics Working Group [8].”
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin dosing: 2017 Update (2017, background): “…Consortium (CPIC) of the National Institute of Health’s Pharmacogenomics Research Network develops peer-reviewed gene/drug guidelines that are published and updated periodically on https://cpicpgx.org/genes-drugs/ and http://www.pharmgkb.org based upon new developments in the field (1).”
- An Evidence‐Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine (2021, background): “10 CPIC produces genotype-based drug-prescribing guidelines established on extensive literature reviews and expert recommendations.”